[artículo] 
inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2023 - Vol. 62 - No. 5 (Mayo) . - pp. 479-502

Título :	Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders
Tipo de documento:	texto impreso
Autores:	Heather J. Walter, Autor ; A. Reese Abright, Autor ; Oscar G. Bukstein, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 479-502
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Guía de practica clínica, Depresión, Trastornos depresivos, Psiquiatría infantil, Evaluacion psiquiatrica infanto-juvenil - tratamiento.
Resumen:	To enhance the quality of care and clinical outcomes for children and adolescents with major depressive disorder (MDD) and persistent depressive disorder (PDD). The aims are as follows: (1) to summarize empirically based guidance about the psychosocial and psychopharmacologic treatment of MDD and PDD in children and adolescents; and (2) to summarize expert-based guidance about the assessment of these disorders as an integral part of treatment, and the implementation of empirically based treatments for these disorders in clinical practice.
Link:	./index.php?lvl=notice_display&id=29860

[artículo] Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders [texto impreso] / Heather J. Walter, Autor ; A. Reese Abright, Autor ; Oscar G. Bukstein, Autor . - 2023 . - pp. 479-502.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2023 - Vol. 62 - No. 5 (Mayo) . - pp. 479-502

Palabras clave:	Guía de practica clínica, Depresión, Trastornos depresivos, Psiquiatría infantil, Evaluacion psiquiatrica infanto-juvenil - tratamiento.
Resumen:	To enhance the quality of care and clinical outcomes for children and adolescents with major depressive disorder (MDD) and persistent depressive disorder (PDD). The aims are as follows: (1) to summarize empirically based guidance about the psychosocial and psychopharmacologic treatment of MDD and PDD in children and adolescents; and (2) to summarize expert-based guidance about the assessment of these disorders as an integral part of treatment, and the implementation of empirically based treatments for these disorders in clinical practice.
Link:	./index.php?lvl=notice_display&id=29860